Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Brachytherapy

Published by: Global Industry Analysts

Published: Jul. 1, 2009 - 227 Pages


Table of Contents


I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITION

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definition and Scope of Study

Implantable Prostate Seeds Brachytherapy

Post-Operative Brachytherapy

II. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Cancer - A Major Health Concern

Quick Cancer Statistics

Table 1: Worldwide New Cancer Cases (2007) -Percentage Share Breakdown by Region (includes corresponding Graph/Chart)



Table 2: Worldwide New Cancer Cases (2007) -Percentage Share by Region and Sex (includescorresponding Graph/Chart)

Growing Cancer Cases in Developing Countries

Table 3: Worldwide Cancer Causes (%) by Level of Economic Development (includes corresponding Graph/Chart)

2.BRACHYTHERAPY MARKET

Brachytherapy - A Prelude

Growth Driving Factors

Brachytherapy Provides Hope for Cancer Patients

Growing Brachytherapy Acceptance

Aging Population: An Important Demographic Driver

Prostate Brachytherapy Offers Bright Prospects

Reimbursement Scenario

Competition Heats Up in the Brachytherapy Market

Macular Degeneration - An Emerging BrachytherapyApplication

APBI Therapy Rise in Popularity

Balloon Brachytherapy Gains Prominence

3.BRACHYTHERAPY - AN INTRODUCTION

What is Brachytherapy?

Implantable Prostate Seeds Brachytherapy

Post-Operative Brachytherapy

Mechanism of Action

Brachytherapy - Under the Microscope

Brachytherapy Sources

The Team

Historical Perspective

Brachytherapy - A Classification

Types As Per Seed Positioning

Mold Brachytherapy

Interstitial Brachytherapy

Endovascular Brachytherapy

Stent-Based Techniques

Catheter-Based Techniques

Intracavitary Brachytherapy

Classification As Per Irradiation Duration

Temporary Brachytherapy

Permanent Brachytherapy

Categorization As Per the Dose Rate

HDR Brachytherapy

LDR Brachytherapy

PDR Brachytherapy

PDR Brachytherapy Vs HDR Brachytherapy

PDR Brachytherapy Vs LDR Brachytherapy

4.BRACHYTHERAPY EQUIPMENT

Brachytherapy Systems

Remote Afterloading Machines

Manual Afterloading Machines

Brachytherapy Applicators

Types of Brachytherapy Applicators

Automated Brachytherapy Applicators

Manual Brachytherapy Applicators

5.PROSTATE CANCER - A MAJORBRACHYTHERAPY INDICATION

Prostate Cancer - A Deadly Disease

Brachytherapy Revolutionizes Prostate Cancer Treatment

History Behind the Development

Prostate Brachytherapy Procedure

Seed Brachytherapy Clinical Outcomes

Side Effects Do Exist

Types of Brachytherapy Procedures for ProstateCancer Treatment

Interstitial Brachytherapy

Combination Radiotherapy

Whole Pelvic Radiation Therapy

Seed Migration - A Cause of Concern?

6.OTHER MAJOR BRACHYTHERAPYINDICATIONS

Breast Cancer

Breast Brachytherapy - An Introduction

How is Breast Brachytherapy Performed?

Breast Brachytherapy Techniques

Brain Brachytherapy

Brain Tumor

Types of Brain Tumor

Treatment Techniques

Brain Brachytherapy

Whole Brain Radiation Therapy

Bronchial Carcinoma

Bronchial Brachytherapy

Procedure

Head and Neck Brachytherapy

Cervical Brachytherapy

Esophageal Brachytherapy

Brachytherapy for Eyelid Tumors

Other Indications

7.RESEARCH/STUDY FINDINGS

CyberKnife® Effective for HDR Brachytherapy

SAVI Breast Brachytherapy Offers Enhanced DoseControl

Electronic Brachytherapy Treats Early Stage BreastCancer

Brachytherapy Treats Head And Neck Cancers

Brachytherapy and External Radiation Therapy OfferImpressive Outcomes

Brachytherapy Effective in Single Brain MetastasesTreatment

MRI-based Brachytherapy Treats Cervical Cancer

8.PRODUCT INNOVATIONS/INTRODUCTIONS

Varian Medical Systems Launch VariSeed 8.0

Nucletron Introduces 3 New Brachytherapy Products

Xoft to Launch Axxent Xpress™ Mobile ElectronicBrachytherapy Vehicles

SenoRx Launches Contura Multi-Lumen Balloon Catheter

BrachySciences Introduces TheraSeed® Palladium-103Isotope AnchorSeed

Cianna Medical Launches New Version of SAVI™Applicator

Nucletron Introduces Oncentra® Brachy Cancer TreatmentSolution

Varian to Introduce New RapidArc RadiotherapyTechnology

Prowess Launches Inverse Planning BrachytherapySystem

IBA Introduces New COMPACT Proton TherapySystem

Varian Introduces Brachytherapy Treatment PlanningSystem

Nucletron Unveils IPSA for HDR Brachytherapy

B-K Medical Introduces New Transducer

FDA Approves NASI’s New Range of BrachytherapyOfferings

NASI Launches ClearPath™

BioLucent Launches Innovative SAVI Device for BreastBrachytherapy

9.RECENT INDUSTRY ACTIVITY

IsoRay and BrachySciences Ink Distribution Agreement

North American Scientific Agrees to Divest ProstateBrachytherapy Products

IsoRay Receives Health Canada’s Approvalfor Selling Proxcelan Cs-131

Nucletron Enters into Partnership with Isodose Control

Xoft Gains FDA Approval for Applicators

Varian Medical Collaborates with BK Medical

Oncologix Inks MoU with IUT

NeoVista Gains Approval from BSI Product Services

Xoft and Elekta Inks an Agreement

IsoRay Acquires Minority Stake in UralDial

IBt-BEBIG Receives Supply Contract from HospitalUniversitario Ramón y Cajal

Eckert & Ziegler to Supply Radiation Therapy Products toSpanish Hospitals

North American Scientific Changes Name to NAS Medical

Theragenics Acquires NeedleTech

Implant to Divest IP and Medical Assets of BrachytherapyProducts Business

IBt to Form Joint Venture with RNT and 000 Bebig

Nucletron and AKH/MUW Extend Cooperation withMulti-Tiered Partnership

IsoAid Secures 3-Year Contract for Supply ofBrachytherapy Products

Envisioneering Inks Distribution Agreement withIsodose Control

Biocompatibles Acquires BrachySciences

Nucletron and BrachySolutions Form Partnership

SIUT Inaugurates New Brachytherapy Center

IBt to Acquire Brachytherapy Business Segments fromEZAG

North American Scientific Enters into an Agreement with Carbon Medical

Varian Receives FDA Approval for BrachytherapyApplicator

IBt Completes Acquisition of Urorad

IsoRay Inks an Agreement with Applied ProcessEngineering Laboratory

International Brachytherapy Inks an Agreement with IBA

IsoRay Medical Inks Letter of Intent with International Brachytherapy

IsoRay Medical to Shift Production Facility to APELin Richland

Radiation Therapy Services Acquires Radiation TherapyFacility

Hologic Plans BioLucent Acquisition

Core Oncology Acquires Mills Biopharmaceuticals

International Isotopes Takes Over Minority Stakein RadQual

ONCURA Inks Agreement with Premier

MDS Nordion and Best Medical International Signan Agreement

North American Scientific Divests NOMOS® to BestMedical International

Premier Renews Contract with North American Scientific

Sirtex Expands its Research and Development Program

Xoft Axxent™ Electronic Brachytherapy System ReceivesFDA Approval

North American Scientific Launches Initiative for BreastBrachytherapy

Coloplast Acquires Urology Business Unit of Mentor

Implant Sciences Signs an Agreement with InternationalBrachytherapy

BrachySciences Enters into Distribution Agreementwith Envisioneering

IBt Inks a Distribution Agreement with Isodose Control

ONCURA Inks an Agreement with Novation and UHC

ONCURA Inks an Agreement with HealthTrustPurchasing Group

IsoRay Commences Cesium-131 Production Testing

InterCommunity Cancer Center Offers Cesium-131for Prostrate Cancer

10.OTHER DEVELOPMENTS

The U.S. Patent and Trademark Office Issues Patentsfor SAVI™

Sirtex Obtains FDA Approval for Producing SIR-Spheres®Microspheres

MDS Nordion Secures FDA Approval for TheraSphere®

Health Commission Wales to Provide BrachytherapyServices in Wales

IBt Receives Reimbursement for InterStrand-125and InterSource-125

MDS Nordion Sets Up Centers of Excellence forTheraSphere®

Aarhus University Hospital Begins Using IGBT

WellStar Kennestone Hospital Acquires Axxent ElectronicBrachytherapy System

Silicon Valley Urology Center Starts Using Cesium-131

MDS Nordion Receives US FDA Approval toTest Efficacy of TheraSphere®

ONCURA Bags Contract to Supply Seeds toThe Cookridge Hospital

11.FOCUS ON SELECT GLOBAL PLAYERS

Best Medical International, Inc. (US)

Best Vascular, Inc. (US)

BrachySciences, Inc. (US)

Core Oncology (US)

C. R. Bard, Inc. (US)

Cytyc Corporation (US)

Eckert & Ziegler Strahlen- und Medizintechnik AG(Germany)

International Brachytherapy SA (Belgium)

NAS Medical (US)

Oncura, Inc. (US)

Sirtex Medical Ltd. (Australia)

Theragenics Corporation (US)

Varian Medical Systems, Inc. (US)

Xoft, Inc. (US)

III. MARKET

1.THE UNITED STATES

A. Market Analysis

Current & Future Analysis

Cancer Presumes Epidemic Proportion

A Glance at Cancer Statistics

Table 4: Cancer-Affected Population in the US (2007): Percentage Share Breakdown by Cancer Type(includes corresponding Graph/Chart)



Table 5: US New Cancer Cases (2008) - PercentageShare Breakdown by Leading State (includes corresponding Graph/Chart)

Growing Cancer Prevalence Drives BrachytherapyDemand

Brachytherapy - Effective Option for CancerTreatment

Rapid Growth in Prostate Brachytherapy Market

Leading Players

Table 6: Leading Players in the US Implantable Seeds Brachytherapy Market (2009E): Percentage Share Breakdown of Sales for Oncura Corp., CR Bard, andOthers (includes corresponding Graph/Chart)

Technology Advancements Accelerate Growth

Breast Brachytherapy Witnesses Slow Growth

Balloon Brachytherapy Making Inroads intoMainstream Market

Competitive Scenario

Table 7: US Balloon Brachytherapy Market (2008): Percentage Value Share Breakdown by Leading Company - Cytyc, SenoRx, and Xoft (includes corresponding Graph/Chart)

Reimbursement Scenario

Growth Drivers

Positive Research Results Drive Acceptance ofBrachytherapy

Market Consolidation Drives Growth

New Developments Propel Market Growth

Product Launches

Strategic Corporate Developments

Other Developments

Key Players

B. Market Analytics

Table 8: US Recent Past, Current & Future Analysis for Brachytherapy: Annual Number of Implantable ProstateSeed and Post-Operative Brachytherapy Proceduresfor Years 2005 through 2015 (in Thousands)(includes corresponding Graph/Chart)



Table 9: US 10-Year Perspective for Brachytherapy by Segment - Percentage Breakdown of ImplantableProstate Seed and Post-Operative BrachytherapyProcedures for Years 2006, 2009 & 2015



Table 10: US Recent Past, Current & Future Analysis for Brachytherapy by Segment - Implantable Prostate Seedand Post-Operative Brachytherapy Procedures Markets Independently Analyzed with Annual Revenues inUS$ Million for Years 2005 through 2015(includes corresponding Graph/Chart)



Table 11: US 10-Year Perspective for Brachytherapyby Segment - Percentage Breakdown of Revenues for Implantable Prostate Seed and Post-SurgicalBrachytherapy Markets for Years 2006, 2009 & 2015



Table 12: US Recent Past, Current & Future Analysisfor Endovascular Brachytherapy Market with Annual Revenues in US$ Million for Years 2005 through2015 (includes corresponding Graph/Chart)

2.EUROPE

A. Market Analysis

Market Outlook

Brachytherapy in Europe

Seed Brachytherapy Market - An Overview

Strategic Initiatives to Drive Growth

Leading Players

Table 13: Leading Players in the European Implantable Prostate Seeds Market (Iodine) (2009E): Percentage Breakdown of Value Sales for Oncura Corp.,C.R. Bard, and Others (includes corresponding Graph/Chart)

Reimbursement Changes Accelerate RadiationSeed Sales

Prostate Brachytherapy Gains Strength

Prostate Seed Market

An Overview

Competitive Analysis

Seed Pricing Analysis

Table 14: Average Prices of Prostate BrachytherapySeeds for the years 2003 & 2010

A Focus on the French Market

UK Prostate Brachytherapy Market - An Overview

Strategic Corporate Developments

Key Players

B. Market Analytics

Table 15: European Recent Past, Current & Future Analysis for Brachytherapy: Annual Number of Implantable Prostate Seed and Post-Operative Brachytherapy Proceduresfor Years 2005 through 2015 (in Thousands)(includes corresponding Graph/Chart)



Table 16: European 10-Year Perspective for Brachytherapy by Segment - Percentage Breakdown of ImplantableProstate Seed and Post-Operative BrachytherapyProcedures for Years 2006, 2009 & 2015



Table 17: European Recent Past, Current & Future Analysis for Brachytherapy by Segment - Implantable Prostate Seed and Post-Operative Brachytherapy Procedures Markets Independently Analyzed with Annual Revenues in US$Million for Years 2005 through 2015 (includescorresponding Graph/Chart)



Table 18: European 10-Year Perspective forBrachytherapy by Segment - Percentage Breakdownof Annual Revenues for Implantable Prostate Seedand Post-Operative Brachytherapy Markets forYears 2006, 2009 & 2015

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 38 (including Divisions/Subsidiaries - 51)

Region/Country Players

The United States

Canada

Europe

Germany

The United Kingdom

Italy

Rest of Europe

Asia-Pacific (Excluding Japan)

Abstract

This report analyzes the Global Market for Brachytherapy in Millions of US$. The ‘Brachytherapy’ market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts are provided for the period of 2005 through 2015. The report profiles 38 companies including many key and niche players worldwide such as Best Medical International, Inc., Best Vascular, Inc., BrachySciences, Inc., Core Oncology, C. R. Bard, Inc., Cytyc Corporation, Eckert & Ziegler Strahlen- und Medizintechnik AG, International Brachytherapy SA, NAS Medical, Oncura, Inc., Sirtex Medical Ltd., Theragenics Corporation, Varian Medical Systems, Inc., and Xoft, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report

Price and Delivery Options

See related reports or call the number above for help from a research specialist.


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009